Logo

Celera Closes $33M Atria Acquisition

Oct 24, 2007
NEW YORK (GenomeWeb News) — Celera today said it has closed its $33 million acquisition of Atria Genetics, a maker of human leukocyte antigen-testing products used in organ donor matching.
 
Celera said it plans to integrate all of Atria’s 13 employees into its company.
 
Celera also said it expects the acquisition will be accretive to its earnings by the second half of 2008.
 
The company disclosed its plans to buy the South San Francisco, Calif.-based company last month.

Breaking News
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.